ferric ferrocyanide has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Duan, Y; Guan, W; Jiang, J; Liu, W; Sun, Y; Zhang, Z; Zhu, Y | 1 |
| Chen, Y; Jiang, J; Qi, J; Yao, X; Zhu, Y | 1 |
2 other study(ies) available for ferric ferrocyanide and Cancer of Prostate
| Article | Year |
|---|---|
In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles.
Topics: Animals; Antigens, Surface; Cell Line, Tumor; Contrast Media; Ferric Compounds; Ferrocyanides; Glutamate Carboxypeptidase II; Humans; Lactic Acid; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Nanotechnology; Neoplasm Transplantation; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Protein Binding; Signal Transduction | 2015 |
Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticles.
Topics: Cell Line, Tumor; Cell Survival; Ferric Compounds; Ferrocyanides; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Prostatic Neoplasms; Staining and Labeling; Transfection | 2011 |